References
- . Graci JD, Cameron CE. Mechanisms of action of ribavirin against distinct viruses. Rev Med Virol. 2006;16(1):37–48
- . Rebetol [package insert]. Kenilworth, NJ: Schering-Plough; December 2007
- . Ribasphere [package insert]. Greenville, NC: Three Rivers Pharmaceuticals; April 2004
- . Copegus [package insert]. Nutley, NJ: Roche; April 2008
- . Virazole [package insert]. Aliso Viejo, CA: Valeant Pharmaceuticals International; April 2002.http://www.valeant.com/fileRepository/products/PI.Virazole_Inhalation%20Solution%206gm_PI_Apr02.pdf. Accessed February 3, 2009
- . US Department of Health and Human Services, US Food and Drug Administration. Code of Federal Regulations. Emergency Use of an Investigational New Drug (IND) Title 21, Part 312.36. Washington, DC: US Dept of Health and Human Services; 2008
- . US Department of Health and Human Services, US Food and Drug Administration. Expanded Access to Investigational New Drugs for Treatment Use. Federal Register 71. December 14, 2006:75148–75149. Washington, DC: US Dept of Health and Human Services; 2006
- . Investigational Drug Brochure. Virazole® (Ribavirin USP) Injection, 2004 edition
- . US Food and Drug Administration. Annual Reports. Code of Federal Regulations. Title 21, Food and Drugs. Part 312.33. Silver Spring, MD: US Food and Drug Administration; 2008
- . Neofytos D, Ojha A, Mookerjee B, . Treatment of adenovirus disease in stem cell transplant recipients with cidofovir. Biol Blood Marrow Transplant. 2007;13(1):74–81
- . Feuchtinger T, Lang P, Handgretinger R. Adenovirus infection after allogeneic stem cell transplantation. Leuk Lymphoma. 2007;48(2):244–255
- . Refaat M, McNamara D, Teuteberg J, . Successful cidofovir treatment in an adult heart transplant recipient with severe adenovirus pneumonia. J Heart Lung Transplant. 2008;27(6):699–700
- . Paduch DA. Viral lower urinary tract infections. Curr Urol Rep. 2007;8(4):324–335
- . Huggins JW, Hsiang CM, Cosgriff TM, . Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J Infect Dis. 1991;164(6):1119–1127
- . Avendano M, Derkach P, Swan S. Clinical course and management of SARS in health care workers in Toronto: a case series. CMAJ. 2003;168(13):1649–1660
- . Booth CM, Matukas LM, Tomlinson GA, . Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA. 2003;289(21):2801–2809
- . Chan TY, Miu KY, Tsui CK, Yee KS, Chan MH. A comparative study of clinical features and outcomes in young and older adults with severe acute respiratory syndrome. J Am Geriatr Soc. 2004;52(8):1321–1325
- . Chapman LE, Mertz GJ, Peters CJ, . Intravenous ribavirin for hantavirus pulmonary syndrome: safety and tolerance during 1 year of open-label experience. Antivir Ther. 1999;4(4):211–219
- . Lewinsohn DM, Bowden RA, Mattson D, Crawford SW. Phase I study of intravenous ribavirin treatment of respiratory syncytial virus pneumonia after marrow transplantation. Antimicrob Agents Chemother. 1996;40(11):2555–2557
- . Lam CW, Chan MH, Wong CK. Severe acute respiratory syndrome: clinical and laboratory manifestations. Clin Biochem Rev. 2004;25(2):121–132
- . Li N, Wang GF, Wu YF, . Side effects of glucocorticosteroids in the management of 1291 patients of SARS. Beijing Da Xue Xue Bao. 2004;36(5):519–524
- . Knowles SR, Phillips EJ, Dresser L, Matukas L. Common adverse events associated with the use of ribavirin for severe acute respiratory syndrome in Canada. Clin Infect Dis. 2003;37(8):1139–1142
- . Muller MP, Dresser L, Raboud J, ; Canadian SARS Research Network. Adverse events associated with high-dose ribavirin: evidence from the Toronto outbreak of severe acute respiratory syndrome. Pharmacotherapy. 2007;27(4):494–503
- . Tai DY. Pharmacologic treatment of SARS: current knowledge and recommendations. Ann Acad Med Singapore. 2007;36(6):438–443
- . Forni AL, Schluger NW, Roberts RB. Severe measles pneumonitis in adults: evaluation of clinical characteristics and therapy with intravenous ribavirin. Clin Infect Dis. 1994;19(3):454–462
- . Yazici Y. Some concerns about adverse event reporting in randomized clinical trials. Bull NYU Hosp Jt Dis. 2008;66(2):143–145
Appendix
- . Aebi C, Headrick CL, McCracken GH, Lindsay CA. Intravenous ribavirin therapy in a neonate with disseminated adenovirus infection undergoing extracorporeal membrane oxygenation: pharmacokinetics and clearance by hemofiltration. J Pediatr. 1997;130(4):612–615
- . Arav-Boger R, Echavarria M, Forman M, Charache P, Persaud D. Clearance of adenoviral hepatitis with ribavirin therapy in a pediatric liver transplant recipient. Pediatr Infect Dis J. 2000;19(11):1097–1100
- . Avendano M, Derkach P, Swan S. Clinical course and management of SARS in health care workers in Toronto: a case series. CMAJ. 2003;168(13):1649–1660
- . Bitnun A, Allen U, Heurter H, ; Other Members of the Hospital for Sick Children SARS Investigation Team. Children hospitalized with severe acute respiratory syndrome-related illness in Toronto. Pediatrics. 2003;112(4):e261
- . Booth CM, Matukas LM, Tomlinson GA, . Clinical features and short-term outcomes of 144 patients with SARS in the greater Toronto area. JAMA. 2003;289(21):2801–2809
- . Bordigoni P, Carret AS, Venard V, Witz F, Le Faou A. Treatment of adenovirus infections in patients undergoing allogenic hematopoietic stem cell transplantation. Clin Infect Dis. 2001;32(9):1290–1297
- . Campbell C, Levin S, Humphreys P, Walop W, Brannan R. Subacute sclerosing panencephalitis: results of the Canadian Pediatric Surveillance Program and review of literature. BMC Pediatr. 2005;5:47
- . Cassano WF. Intravenous ribavirin therapy for adenovirus cystitis after allogenic bone marrow transplantation. Bone Marrow Transplant. 1991;7(3):247–248
- . Chakrabarti S, Collingham KE, Fegan CD, Milligan DW. Fulminant adenovirus hepatitis following unrelated bone marrow transplantation: failure of intravenous ribavirin therapy. Bone Marrow Transplant. 1999;23(11):1209–1211
- . Chan TY, Miu KY, Tsui CK, Yee KS, Chan MH. A comparative study of clinical features and outcomes in young and older adults with severe acute respiratory syndrome. J Am Geriatr Soc. 2004;52(8):1321–1325
- . Chapman LE, Mertz GJ, Peters CJ, . Intravenous ribavirin for hantavirus pulmonary syndrome: safety and tolerance during 1 year of open-label experience. Ribavirin Study Group. Antivir Ther. 1999;4(4):211–219
- . Choi KW, Chau TN, Tsang O, ; Princess Margaret Hospital SARS Study Group. Outcomes and prognostic factors in 267 patients with severe acute respiratory syndrome in Hong Kong. Ann Intern Med. 2003;139(9):715–723
- . Dwosh HA, Hong HH, Austgarden D, Herman S, Schabas R. Identification and containment of an outbreak of SARS in a community hospital. CMAJ. 2003;168(11):1415–1420
- . Emovon OE, Lin A, Howell DN, . Refractory adenovirus infection after simultaneous kidney-pancreas transplantation: successful treatment with intravenous ribavirin and pooled human intravenous immunoglobulin. Nephrol Dial Transplant. 2003;18(11):2436–2438
- . Field K, Slavin MA, Seymour JF. Severe respiratory syncytial virus pneumonia complicating fludarabine and cyclophosphamide treatment of chronic lymphocytic leukemia. Eur J Haematol. 2002;69(1):54–57
- . Gavin PJ, Katz BZ. Intravenous ribavirin treatment for severe adenovirus disease in immunocompromised children. Pediatrics. 2002;110(1 pt 1):e9
- . Glanville AR, Scott AI, Morton JM, . Intravenous ribavirin is a safe and cost-effective treatment for respiratory syncytial virus infection after lung transplantation. J Heart Lung Transplant. 2005;24(12):2114–2119
- . Gomersall CD, Joynt GM, Lam P, . Short-term outcome of critically ill patients with severe acute respiratory syndrome. Intensive Care Med. 2004;30(3):381–387
- . Hale GA, Heslop HE, Krance RA, . Adenovirus infection after pediatric bone marrow transplantation. Bone Marrow Transplant. 1999;23(3):277–282
- . Hara S, Kimura H, Hoshino Y, . Combination therapy with intraventricular interferon-alpha and ribavirin for subacute sclerosing panencephalitis and monitoring measles virus RNA by quantitative PCR assay. Brain Dev. 2003;25(5):367–369
- . Hayden FG, Sable CA, Connor JD, Lane J. Intravenous ribavirin by constant infusion for serious influenza and parainfluenza infection. Antivir Ther. 1996;1(1):51–56
- . Hohenthal U, Nikoskelainen J, Vainionpää R, . Parainfluenza virus type 3 infections in a hematology unit. Bone Marrow Transplant. 2001;27(3):295–300
- . Hopkins PM, Williamson SM, Kermeen FD, . Human metapneumovirus—the first series of a new virulent infection in lung transplant recipients. J Heart Lung Transplant. 2005;24(2):S78–S79
- . Hosoya M, Mori S, Tomoda A, . Pharmacokinetics and effects of ribavirin following intraventricular administration for treatment of subacute sclerosing panencephalitis. Antimicrob Agents Chemother. 2004;48(12):4631–4635
- . Hromas R, Clark C, Blanke C, . Failure of ribavirin to clear adenovirus infection in T cell-depleted allogenic bone marrow transplantation. Bone Marrow Transplant. 1994;14(4):663–664
- . Huggins JW, Hsiang CM, Cosgriff TM, . Prospective, double-blind, concurrent, placebo-controlled clinical trial of intravenous ribavirin therapy of hemorrhagic fever with renal syndrome. J Infect Dis. 1991;164(6):1119–1127
- . Jurado Chacón M, Hernández Mohedo F, Navarro Marí JM, Ferrer Chaves C, Escobar Vedia JL, de Pablos Gallego JM. Adenovirus pneumonitis successfully treated with intravenous ribavirin. Haematologica. 1998;83(12):1128–1129
- . Jurado M, Navarro JM, Hernández J, Molina MA, De Pablos JM. Adenovirus-associated haemorrhagic cystitis after bone marrow transplantation successfully treated with intravenous ribavirin. Bone Marrow Transplant. 1995;15:651–652
- . Kapelushnik J, Or R, Delukina M, Nagler A, Livni N, Engelhard D. Intravenous ribavirin therapy for adenovirus gastroenteritis after bone marrow transplantation. J Pediatr Gastroenterol Nutr. 1995;21(1):110–112
- . Kilgore PE, Ksiazek TG, Rollin PE, . Treatment of Bolivian hemorrhagic fever with intravenous ribavirin. Clin Infect Dis. 1997;24(4):718–722
- . Knowles SR, Phillips EJ, Dresser L, Matukas L. Common adverse events associated with the use of ribavirin for severe acute respiratory syndrome in Canada. Clin Infect Dis. 2003;37(8):1139–1142
- . Kramer TH, Gaar GG, Ray CG, Minnich L, Copeland JG, Connor JD. Hemodialysis clearance in intravenously administered ribavirin. Antimicrob Agents Chemother. 1990;34(3):489–490
- . Lankester AC, Heemskerk B, Claas EC, . Effect of ribavirin on the plasma viral DNA load in patients with disseminating adenovirus infection. Clin Infect Dis. 2004;38(11):1521–1525
- . La Rosa AM, Champlin RE, Mirza N, . Adenovirus infections in adult recipients of blood and marrow transplants. Clin Infect Dis. 2001;32(6):871–876
- . Lewinsohn DM, Bowden RA, Mattson D, Crawford SW. Phase I study of intravenous ribavirin treatment of respiratory syncytial virus pneumonia after marrow transplantation. Antimicrob Agents Chemother. 1996;40(11):2555–2557
- . Li SS, Cheng C, Fu C, . Left ventricular performance in patients with severe acute respiratory syndrome: a 30-day echocardiographic follow-up study. Circulation. 2003;108(15):1798–1803
- . Liles WC, Cushing H, Holt S, Bryan C, Hackman RC. Severe adenoviral nephritis following bone marrow transplantation: successful treatment with intravenous ribavirin. Bone Marrow Transplant. 1993;12(4):409–412
- . Londergan TA, Walzak MP. Hemorrhagic cystitis due to adenovirus infection following bone marrow transplantation. J Urol. 1994;151(4):1013–1014
- . Mann D, Moreb J, Smith S, Gian V. Failure of intravenous ribavirin in the treatment of invasive adenovirus infection following allogenic bone marrow transplantation: a case report. J Infect. 1998;36(2):227–228
- . McCormick JB, King IJ, Webb PA, . Lassa fever: effective therapy with ribavirin. N Engl J Med. 1986;314:20–26
- . McJunkin JE, Khan R, de los Reyes EC, . Treatment of severe La Crosse encephalitis with intravenous ribavirin following diagnosis by brain biopsy. Pediatrics. 1997;99(2):261–267
- . Mertz GJ, Miedzinski L, Goade D, ; Collaborative Antiviral Study Group. Placebo-controlled, double-blind trial of intravenous ribavirin for the treatment of hantavirus cardiopulmonary syndrome in North America. Clin Infect Dis. 2004;39(9):1307–1313
- . Mishra S, Lee WM, Bressler B, Juvet SC, Hadjiliadis D. High dose intravenous methylprednisolone in the treatment of severe acute respiratory syndrome. Can Respir J. 2004;11(4):311–312
- . Miyamura K, Hamaguchi M, Taji H, . Successful ribavirin therapy for severe adenovirus hemorrhagic cystitis after allogenic bone marrow transplant from close HLA donors rather than distant donors. Bone Marrow Transplant. 2000;25(5):545–548
- . Muller MP, Dresser L, Raboud J, ; Canadian SARS Research Network. Adverse events associated with high-dose ribavirin: evidence from the Toronto outbreak of severe acute respiratory syndrome. Pharmacotherapy. 2007;27(4):494–503
- . Murphy GF, Wood DP Jr, McRoberts JW, Henslee-Downey PJ. Adenovirus-associated hemorrhagic cystitis treated with intravenous ribavirin. J Urol. 1993;149(3):565–566
- . Peiris JSM, Chu CM, Cheng VCC, ; HKU/UCH SARS Study Group. Clinical progression and viral load in a community outbreak of coronavirus-associated SARS pneumonia: a prospective study. Lancet. 2003;361(9371):1767–1772
- . Poutanen SM, Low DE, Henry B, ; Canadian Severe Acute Respiratory Syndrome Study Team. Identification of severe acute respiratory syndrome in Canada. N Engl J Med. 2003;348(20):1995–2005
- . Raza K, Ismailjee SB, Crespo M, . Successful outcome of human metapneumovirus (hMPV) pneumonia in a lung transplant recipient treated with intravenous ribavirin. J Heart Lung Transplant. 2007;26(8):862–864
- . Rezvani M, Koren G. Pregnancy outcome after exposure to injectable ribavirin during embryogenesis. Reprod Toxicol. 2006;21(1):113–115
- . Schleuning M, Buxbaum-Conradi H, Jäger G, Kolb HJ. Intravenous ribavirin for eradication of respiratory syncytial virus (RSV) and adenovirus isolates from the respiratory and/or gastrointestinal tract in recipients of allogeneic hematopoietic stem cell transplants. Hematol J. 2004;5(2):135–144
- . Shek CC, Ng PC, Fung GP, . Infants born to mothers with severe acute respiratory syndrome. Pediatrics. 2003;112(4):e254
- . Shetty AK, Gans HA, So S, Millan M, Arvin AM, Gutierrez KM. Intravenous ribavirin therapy for adenovirus pneumonia. Pediatr Pulmonol. 2000;29(1):69–73
- . Sit SC, Yau EK, Lam YY, . A young infant with severe acute respiratory syndrome. Pediatrics. 2003;112(4):e257
- . Solomon T, Hart CA, Vinjamuri S, Beeching NJ, Malucci C, Humphrey P. Treatment of subacute sclerosing panencephalitis with interferon-alpha, ribavirin, and inosiplex. J Child Neurol. 2002;17(9):703–705
- . Tang HL, Cheuk A, Chu KH, . Severe acute respiratory syndrome in haemodialysis patients: a report of two cases. Nephrol Dial Transplant. 2003;18:2178–2181
- . Tatter SB, Carlos RA, O'Donovan CA. Intraparenchymal alpha interferon and intraventricular ribavirin for subacute sclerosing panencephalitis (SSPE). Neurology. 2000;54:A430
- . Tomoda A, Shiraishi S, Hosoya M, Hamada A, Miike T. Combined treatment with interferon-alpha and ribavirin for subacute sclerosing panencephalitis. Pediatr Neurol. 2001;24(1):54–59
- . Tomoda A, Nomura K, Shiraishi S, . Trial of intraventricular ribavirin therapy for subacute sclerosing panencephalitis in Japan. Brain Dev. 2003;25(7):514–517
- . Tsang KW, Ho PL, Ooi GC, . A cluster of cases of severe acute respiratory syndrome in Hong Kong. N Engl J Med. 2003;348(20):1977–1985
- . Warrell MJ, White NJ, Looareesuwan S, . Failure of interferon alpha and ribavirin in rabies encephalitis. BMJ. 1989;299:830–833
- . Willoughby RE Jr, Tieves KS, Hoffman GM, . Survival after treatment of rabies with induction of coma. N Engl J Med. 2005;352(24):2508–2514
- . Wong PN, Mak SK, Lo KY, . Clinical presentation and outcome of severe acute respiratory syndrome in dialysis patients. Am J Kidney Dis. 2003;42(5):1075–1081
- . Wright JJ, O'Driscoll G. Treatment of parainfluenza virus 3 pneumonia in a cardiac transplant recipient with intravenous ribavirin and methylprednisolone. J Heart Lung Transplant. 2005;24(3):343–346
- . Wulffraat NM, Geelen SPM, van Dijken PJ, de Graeff-Meeder B, Kuis W, Boven K. Recovery from adenovirus pneumonia in a severe combined immunodeficiency patient treated with intravenous ribavirin. Transplantation. 1995;59(6):927
- . Zhao Z, Zhang F, Xu M, . Description and clinical treatment of an early outbreak of severe acute respiratory syndrome (SARS) in Guangzhou, PR China. J Med Microbiol. 2003;52(pt 8):715–720